The Percentage of Cases of Acute Treatment With Allopurinol in Gout Patients

Not Applicable

• Conditions: Gout
• Interventions: Drug: Allopurinol

• Registration Number: NCT03601260
• Lead Sponsor: Hillel Yaffe Medical Center

Brief Summary

The aim of the study is to determine the percentage of cases of acute treatment with Allopurinol in gout patients who have been previously treated.

Detailed Description

Not available

Study Timeline

• Status Verified: 2018-07
• Study First Submitted: 2018-07-18
• Study First Submitted QC: 2018-07-18
• Last Update Submitted: 2018-07-18
• Study First Posted: 2018-07-26
• Last Update Posted: 2018-07-26
• Study Start: 2018-08
• Primary Completion: 2018-12
• Study Completion: 2018-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 700

Inclusion Criteria

• Gout patients

Exclusion Criteria

• Pregnant women
• Chronic renal failure
• Patients with Allopurinal hypersensitivity

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Gout Patients	Allopurinol	Allopurinol 100 mg-300mg/day as secondary treatment in gout patients

Primary Outcome Measures

Name	Time	Method
Gout patients treated with Allopurinol	Six months	Retrospective identification through medical records of percentage of gout patients treated with Allopurinol

Secondary Outcome Measures

Name	Time	Method
Patients with contraindication to Allopurinol	Six months	Retrospective identification through medical records of percentage of gout patients with contraindications to Allopurinol

Trial Locations

Locations (1)

Hillel Yaffe Medical Center; 🇮🇱 Hadera, Israel